| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.00 | 0.00 (--%) | -- - -- | 0.0 |
Market data as of 12:00AM 06/19/13. Quotes are delayed by at least 15 min.
European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
05/21/2013 4:30 PM ET
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacroâ„¢ to Improve Tacrolimus-Induced Tremors
05/20/2013 3:00 AM ET
Veloxis Pharmaceuticals announces financial results for the first three months of 2013
05/15/2013 1:00 PM ET